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Abstract: Platelet-derived growth factor B (PDGFB) released from endothelial cells is indispensable
for pericyte recruitment during angiogenesis in embryonic and postnatal organ growth. Constitutive
genetic loss-of-function of PDGFB leads to pericyte hypoplasia and the formation of a sparse, dilated
and venous-shifted brain microvasculature with dysfunctional blood-brain barrier (BBB) in mice, as
well as the formation of microvascular calcification in both mice and humans. Endothelial PDGFB is
also expressed in the adult quiescent microvasculature, but here its importance is unknown. We show
that deletion of Pdgfb in endothelial cells in 2-months-old mice causes a slowly progressing pericyte
loss leading, at 12-18 months of age, to ฀50% decrease in endothelial:pericyte cell ratio, ฀60% decrease
in pericyte longitudinal capillary coverage and >70% decrease in pericyte marker expression. Similar
to constitutive loss of Pdgfb, this correlates with increased BBB permeability. However, in contrast
to the constitutive loss of Pdgfb, adult-induced loss does not lead to vessel dilation, impaired arterio-
venous zonation or the formation of microvascular calcifications. We conclude that PDFGB expression in
quiescent adult microvascular brain endothelium is critical for the maintenance of pericyte coverage and
normal BBB function, but that microvessel dilation, rarefaction, arterio-venous skewing and calcification
reflect developmental roles of PDGFB.
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Abstract
Platelet-derived growth factor B (PDGFB) released from endothelial cells is indispensable for pericyte recruitment
during angiogenesis in embryonic and postnatal organ growth. Constitutive genetic loss-of-function of PDGFB leads
to pericyte hypoplasia and the formation of a sparse, dilated and venous-shifted brain microvasculature with dysfunc-
tional blood-brain barrier (BBB) in mice, as well as the formation of microvascular calcification in both mice and humans.
Endothelial PDGFB is also expressed in the adult quiescent microvasculature, but here its importance is unknown. We
show that deletion of Pdgfb in endothelial cells in 2-months-old mice causes a slowly progressing pericyte loss leading, at
12–18 months of age, to 50% decrease in endothelial:pericyte cell ratio, 60% decrease in pericyte longitudinal
capillary coverage and >70% decrease in pericyte marker expression. Similar to constitutive loss of Pdgfb, this correlates
with increased BBB permeability. However, in contrast to the constitutive loss of Pdgfb, adult-induced loss does not lead
to vessel dilation, impaired arterio-venous zonation or the formation of microvascular calcifications. We conclude that
PDFGB expression in quiescent adult microvascular brain endothelium is critical for the maintenance of pericyte
coverage and normal BBB function, but that microvessel dilation, rarefaction, arterio-venous skewing and calcification
reflect developmental roles of PDGFB.
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Introduction
Platelet-derived growth factor B (PDGFB), originally
identified as a constituent of PDGF molecules in blood
serum and human platelets, is one of four PDGF
chains (PDGF A-D) that make up the PDGF family
of homo- and heterodimeric ligands.1 The Pdgfb gene
consists of seven exons. Exons 4 and 5 encode the
growth factor core domain and thereby the major
part of the mature protein. A carboxy-terminal motif
mediating heparan sulfate proteoglycan (HSPG) bind-
ing of PDGFB is encoded by exon 6.2,3 Biologically
active PDGFB ligands are usually disulfide-linked
PDGF-BB homodimers and exert their major biologi-
cal effects via the tyrosine kinase receptor platelet-
derived growth factor receptor b (PDGFRB).
The physiological roles of PDGFB have been studied
mainly during development. Embryonic deletion of
either of the Pdgfb or Pdgfrb genes in mice are
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perinatally lethal due to widespread hemorrhage and
general edema.4,5 The complete loss of PDGFB or
PDGFRB proteins results in failure of mural cell (peri-
cyte and vascular smooth muscle cell (VSMC)) prolif-
eration and recruitment to the developing vasculature,
which causes blood vessel dilation and dysfunction.6,7
Furthermore, loss-of-function mutations in the
PDGFB and PDGFRB genes cause primary familial
brain calcification (PFBC), a dominantly inherited
age-dependent neurodegenerative disease, character-
ized by bilateral vessel-associated calcifications in the
basal ganglia.8,9
The Pdgfb retention motif knockout mouse
(Pdgfbret/ret) is a hypomorphic Pdgfb model that has
been used to study postnatal effects of pericyte loss,
particularly in the central nervous system (CNS) vas-
culature.9–15 The Pdgfbret mutation renders a biologi-
cally active PDGFB protein, which however, due to
deletion of the exon 6-encoding domain and resulting
inability of the growth factor to bind extracellular
HSPGs, fails to shape appropriate peri-endothelial
PDGFB gradients that are required to stimulate
proper recruitment of pericytes to the developing vas-
culature.16,17 As a consequence, fewer pericytes are
recruited, which may also be less well integrated in
the vessel wall.12 Pdgfbret/ret mice are adult viable but
show severely reduced brain pericyte coverage (25%
longitudinal coverage as compared with Pdgfbret/þ con-
trols) and a substantially increased capillary diame-
ter.10,15 Pdgfbret/ret mice retain a general Wnt-induced
blood-brain barrier (BBB)-specific gene expression pro-
file but acquire a venous-shifted endothelial profile,
upregulate expression of numerous growth factors
and cytokines, and display angiogenic sprouting and
impaired BBB function caused by increased transcyto-
sis and focal hotspot leakage sites with disrupted endo-
thelial junctions.10,15 Additionally, adult Pdgfbret/ret
mice develop microvascular calcifications in deep
brain regions similarly to PFBC patients.9,13,14
Importantly, endothelial expression of PDGFB pro-
tects mice from vessel calcification,9 indicating that
PDGFB has homeostatic functions in the vessel wall
in addition to pericyte recruitment.
PDGFB is expressed by several cell types in the
brain.1,18,19 In order to analyze the vascular functions
of PDGFB, previous studies have used constitutive
Tie1-Cre to ablate Pdgfb during embryonic develop-
ment.20,21 These mice were viable and reached
adulthood, but deletion of Pdgfb was partial and
inter-individually variable, with 20–90% recombina-
tion efficiencies correlating with 30–90% pericyte loss
in the CNS20. Likewise, early postnatal deletion of
endothelial-specific PDGFB accomplished using
tamoxifen-induced Cdh5-CreERT2 mediated knockout
strategy (P5-P7), demonstrated a crucial role for
PDGFB in recruiting pericytes to developing retinal
capillaries.22 Thus, both constitutive and
developmentally-induced PDGFB knockouts have
invariably displayed BBB and blood-retinal barrier
defects that correlate in severity with the degree of
pericyte hypoplasia, together demonstrating that
PDGFB signaling through PDGFRB is critical for
developmental assembly of functional blood vessels.
However, if PDGFB also has a homeostatic role in
fully developed CNS blood vessels is less understood.
PDGFB continues to be expressed in adult brain endo-
thelium.18 Retinal vasculature in mice with postnatally-
induced (at 8–9 weeks) endothelial Pdgfb knockout
maintained pericyte coverage and displayed an intact
blood-retinal barrier one month later,22 however, the
long-term consequences were not addressed.
In this study, we investigated whether endothelial
PDGFB is required for pericyte and VSMC survival
and maintenance in the fully developed and quiescent
adult brain and retinal vasculature over a prolonged
time period. We deleted Pdgfb in 2-month-old mice
and analyzed them at 4-, 12- and 18-months of age.
Our results show that loss of endothelial PDGFB
leads to a slowly progressing loss of mural cells even-
tually triggering BBB permeability to both low and
high molecular weight tracers. However, we did not
find certain other phenotypes associated with develop-
mental pericyte loss, such as increased capillary diam-
eter and microvascular calcification. Our data thereby
distinguish between developmental and homeostatic
roles for PDGFB in the brain vasculature.
Material and methods
Experimental animals
Endothelial-specific tamoxifen-inducible Pdgfb knock-
out mice (referred to as PdgfbiECKO) were obtained by
crossing Pdgfbflox/flox 20 or Pdgfbflox/ 4,20 mice with
endothelial specific Cdh5(PAC)-CreERT2 mice.23 For
all experiments, Cre negative mice with either
Pdgfbflox/flox or Pdgfbflox/þ genotypes and/or C57BL6
mice are referred to as controls (Ctrl). Gene deletion
was induced by daily tamoxifen (cat. #T5648, Sigma-
Aldrich) administration (100 ll of a 20mg/ml solution
in 90% corn oil (cat. #C8267, Sigma-Aldrich) and 10%
ethanol) by oral gavage for 5 consecutive days at
approximately 2 months of age. To minimize potential
confounders, all animals within each experiment were
treated with the same batch of Tamoxifen. Mice were
sacrificed for brain analysis after 2weeks (1 litter, Ctrl
n¼ 4, PdgfbiECKO n¼ 5) and approximately 2 months
(7 litters, Ctrl n¼ 21, PdgfbiECKO n¼ 25) after
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induction (referred to as “young” mice) or approxi-
mately 10 (5 litters, Ctrl n¼ 15, PdgfbiECKO n¼ 14)
and 16 months (1 litter, Ctrl n¼ 1, PdgfbiECKO n¼ 4)
after induction (referred to as “old” mice). Two of the
control animals in 16 months after induction group
died before analysis, leaving us with only one littermate
control for the comparison. For retinal analysis mice
were taken at approximately 2 months (1 litter, Ctrl
n¼ 3, PdgfbiECKO n¼ 4) and 16 months (1 litter, Ctrl
n¼ 1, PdgfbiECKO n¼ 2) after induction. In addition,
we analyzed non-induced mice (2 litters, Cre negative
n¼ 6, Cre positive n¼ 6) to rule out the possibility of
genetic background influencing the phenotype. For
RNA in situ analysis 3-months-old C57BL/6 (n¼ 3)
mice were used.
Animal housing, as well as the experiments per-
formed, were in accordance with Swedish legislation
and were approved by the Uppsala Committee on the
Ethics of Animal Experiments (permit numbers C224/
12, C115/15, C111515/16). Experiments have been
reported in compliance with the ARRIVE 2.0 guide-
lines.24 All efforts were made to minimize animal suf-
fering. Both male and female mice were used in the
experiments, and the studied phenotypes did not
differ between sexes. All mice were back-crossed at
least 10 generations to C57BL/6 background. No ani-
mals were excluded from the analyses. All quantifica-
tions were carried out with the investigator blinded to
genotype.
In situ RNA hybridization
In situ RNA hybridization was performed using
RNAscope technology (ACDBio) following the manu-
facturer’s protocol with minor modifications as previ-
ously reported.18 The fluorescent signal was captured
using a Leica TCS SP8 confocal microscope (Leica
Microsystems). The following RNAscope probes
from ACDBio were used: Pdgfb (#424651), Pecam1
(#316721) and Tubb3 (#423391). All images presented
are 2D maximum intensity projections of 4 mm
z-stacks. According to the ACDBio, each mRNA mol-
ecule hybridized to a probe appears as a separate small
fluorescent dot.
Microvasculature isolation and quantitative PCR
After perfusion with Hank’s Balanced Salt Solution
(HBSS, #14025092, Life Technologies), one hemi-
sphere of the brain was used for microvasculature iso-
lation and qPCR and the other hemisphere was used
for additional experiments (BBB integrity assessment,
immunofluorescence stainings). The chopped tissue
was incubated with 0.5mg/ml of collagenase type 2
(#C6885, Sigma) in Dulbecco’s Modified Eagle’s
Medium (DMEM, #31885-023, Life Technologies) for
10minutes at 37C. The suspension was neutralized
with DMEM with 20% fetal bovine serum (FBS,
#10500-064, Life Technologies) and filtered through a
70 lm mesh (#352350, BD Biosciences). After centrifu-
gation, the pellet was resuspended in DMEM with
0.5mg/ml heparin (#H3393-100KU, Sigma-Aldrich)
to prevent coagulation. The cell suspension was incu-
bated with sheep anti-rat magnetic Dynabeads
(#11035, Life Technologies) bound to rat anti-mouse
PECAM1 antibody (#AF3628, BD Pharmingen) for
60minutes at 4C. Afterwards, the microvascular frag-
ments were collected with a DynaMag-2 magnet and
washed with DMEM containing 0.5mg/ml of heparin
and lysed in RLT buffer. RNA was extracted with the
RNeasy Plus micro kit (#74034, Qiagen). cDNA was
synthesized using iScript RT Supermix (#170-8841,
BioRad) and quantified using Taqman assays
(Applied Biosystems). The probes used are summarized
in Suppl. Table 1, as well as the number of litters and
animals analyzed. The expression levels of all genes
were normalized to endogenous gene expression levels
of Gapdh.
Immunofluorescence stainings
Mice were perfused transcardially under full anesthesia
(Hypnorm-Midazolam or Ketamine-Xylazine mixture)
with HBSS, followed by 4% buffered formaldehyde
(Formalin, #2178, Histolab). Brains and retinas were
removed and post-fixed in formalin for 4 and 2 h,
respectively, at 4C. Fifty to seventy-five lm brain sag-
ittal vibratome sections and retinas were incubated in
blocking/permeabilization solution (1% bovine serum
albumin (BSA), 0.75% TritonX-100 (#T8787, Sigma-
Aldrich)), 5% normal donkey serum (# 017-000-121,
Jackson ImmunoResearch) in PBS) overnight at 4C,
followed by incubation in primary antibody solution
for 48–72 h at 4C, and subsequently in secondary anti-
body solution overnight at 4C. Sections were mounted
in Prolong Gold anti-fade reagent (#P36930, Thermo
Fischer Scientific). A detailed list of the primary anti-
bodies used for this study can be seen in Suppl. Table 2.
Secondary antibodies from donkey for multiple
labelling conjugated with the appropriate fluorescent
dyes were from ThermoScientific or Jackson
ImmunoResearch. As a negative control the sections
were incubated with secondary antibodies only. Cell
nuclei were visualized with Hoechst 33342 (Hoecsht,
#H3570, ThermoFisher). Image processing was done
using Fiji, Adobe Photoshop 2020 (21.2.3), and
Adobe Illustrator 2020 (24.3). All immunofluorescence
images were taken with Leica TCS SP8 and presented
as maximum intensity projections of confocal z-stacks.
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Quantification of pericyte coverage, endothelial cell
number and length
From cerebral cortex, two 60–75mm-thick vibratome
sections per mouse, five 10.17 mm-thick z-stacks per
section and four 6.78 mm z-stacks for each vascular
plexus in half a retina were obtained with a Leica
TCS SP8 and 40x objective. The sections were co-
immunolabeled with PECAM1, ANPEP, ERG and
the nuclei were visualized with Hoechst. Pericyte cov-
erage was quantified as previously reported.25 In the
brain, all the ERGþ cells per field were counted as
well as all the ANPEPþ cell bodies colocalizing with
Hoechst. The ratio of ERGþ cells over ANPEPþ cell
was considered as the EC/PC ratio per each field.
To study regional differences in pericyte coverage,
three 10.17 mm-thick z-stacks from one section were
obtained. The analysis was done in the hippocampus,
thalamus, midbrain, cerebellar center and corpus callo-
sum. Furthermore, for the pericyte longitudinal cover-
age analysis and vascular length from the midbrain,
two litters of old mice (PdgfbiECKO n¼ 8, Ctrl n¼ 3)
were included. In this case, five z-stacks per section
from two sections were used for the analysis.
Analysis of apoptosis
At 2weeks after induction, two 30 mm-thick sagittal
vibratome sections per mouse brain were collected
and stained for cleaved-CASPASE3 in combination
with ANPEP and PECAM1. Hoechst was used to
localize the nuclei. All cleaved-CASPASE3 positive
cells present on each section were captured and
counted with a Leica TCS SP8 and 63x objective.
Co-immunolabeling of PECAM1 and ANPEP together
with cleaved-CASPASE3 positive cells allowed the
localization of apoptotic endothelial cells and pericytes
or VSMC, respectively. All cleaved-CASPASE3 posi-
tive cells that did not co-localize with either PECAM1
or ANPEP were considered as “other cell type” of apo-
ptotic cells. Representative images are presented as
maximum intensity projections of confocal z-stacks.
Blood-brain barrier and retina integrity assessment
Blood-brain barrier integrity analyses with Alexa Fluor
555 cadaverine (#A30677, Life Technologies, 11 lg/g
body weight) were carried out as previously.15 Results
were expressed as fold change of the controls.
For blood-retina barrier integrity assessment, Alexa
Fluor 555 cadaverine injected mice were perfused 2 h
after tracer administration first with HBSS then fol-
lowed by 4% buffered formaldehyde. The retinas
were dissected and post-fixed in 4% buffered formal-
dehyde for 2 h, at 4C and analyzed with Leica
TCS SP8.
TMR-Dextran hotspot leakage quantification
70 kDa Dextran conjugated to tetramethylrhodamine
(125 mg/g body weight) (TMR, #D1818,
ThermoFisher) was injected intravenously into the
tail vein of tamoxifen-induced 12-month-old mice
16 h before sacrifice. 60–65mm-thick vibratome brain
sections were co-immunostained for PECAM1,
CLDN5 and CDH5. Two sections per mouse were ana-
lyzed and all the present 70 kDa TMR-Dextran hot-
spots were imaged and counted with a Leica TCS
SP8 and 63x objective. Representative images are pre-
sented as maximum intensity projections of confocal
z-stacks.
Statistical analysis
GraphPad Prism v5.01 was used for all the statistical
analysis. Data is presented as geometrical mean geo-
metrical SD. When zero values are present, the data
is presented as mean SD. Shapiro-Wilk and
Kolmogorov-Smirnov test were used to study normal-
ity, when there were no zero values or n was greater
than 1. For normally distributed data with two group
comparisons two-tailed, unpaired student’s t test was
performed. For unevenly distributed data, the non-
parametric Mann Whitney U test was used. For mul-
tiple comparisons with normally distributed data,
Tukey’s multiple comparison test was used, whereas
for unevenly distributed data, the nonparametric
Kruskal-Wallis multiple comparison test was used.
For all tests, P 0.05 was considered statistically sig-
nificant. For group size determination, no formal prior
power calculations were performed. The practical cir-
cumstances determined the number of mice in each
experiment. For all the images included across the
manuscript, the most representative examples reflecting
the typical phenotype were selected.
Results
Pdgfb gene deletion efficiency in adult
PdgfbiECKO mice
Previous work has established that Pdgfb is expressed
by endothelial cells in the developing vasculature,7 in
particular in tip cells of angiogenic sprouts and in
developing arterial endothelial cells.6,26 More recent
single-cell RNA sequencing data show that endothelial
Pdgfb expression is maintained in the adult mouse
brain, and that endothelial cells are the major site of
Pdgfb expression in this organ. However, Pdgfb expres-
sion was also found to a lower extent in VSMC, micro-
glia and certain type of neurons.18,19 Single-cell RNA
sequencing data further suggests that endothelial Pdgfb
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expression occurs at similar levels in arteries, capillaries
and veins.18 Due to a lack of reliable anti-PDGFB anti-
bodies we performed RNA in situ hybridization
experiments on adult mouse brains, which confirmed
co-expression of Pdgfb with the endothelial cell marker
Pecam1 mRNA in vascular structures (Suppl. Fig. 1A),
as well as Pdgfb and the neuronal marker Tubb3 in
certain neurons (Suppl. Fig. 1B).
In order to gain insights into the role of
endothelium-derived PDGFB in the adult quiescent
brain vasculature, we created endothelial-specific
Pdgfb knock-out mice using a tamoxifen-inducible
strategy by crossing either Pdgfbflox/flox,20 Pdgfbflox/þ
or Pdgfbflox/ 7 mice with Cdh5-CreERT2 mice.23
This breeding strategy gave rise to litters including
Cre-positive Pdgfbflox/flox or Pdgfbflox/- mice, which
were collectively used as conditional endothelial cell
PDGFB knock-outs (PdgfbiECKO), as well as Cre-
negative Pdgfbflox/flox or Pdgfbflox/þ pups, which were
collectively used as littermate controls (Ctrl).
PdgfbiECKO and control mice were administered
tamoxifen once per day for five consecutive days at
2-months of age and sacrificed at 4-months of age
(referred to as young age), or 12- or 18-months of
age (collectively referred to as old age) (Figure 1(a)).
Quantitative PCR analysis of microvascular fragments
revealed a substantial reduction in Pdgfb transcript
levels in both young (8% remaining, Figure 1(b)) and
old PdgfbiECKO mice (4% remaining, Figure 1(b)) com-
pared with controls.
Analysis of 2-months-old Cre-positive and Cre-
negative mice without tamoxifen induction showed no
difference in pericyte longitudinal coverage (Suppl.
Fig. 1C, D), endothelial cell:pericyte ratio (Suppl.
Fig. 1E), vascular length (Suppl. Fig. 1F) or total
number of ERGþ endothelial cells per field (Suppl.
Fig. 1G). Additionally, we did not detect any active
angiogenesis by staining for tip cell marker MCAM15
together with PECAM1, which indicates that the brain
vasculature is largely quiescent at 2 months of age
(Suppl. Fig. 1H).
Endothelium-derived PDGFB is necessary for
maintenance of pericyte coverage in adult
mouse brain vasculature
Reduced density of mural cells is a well-characterized
consequence of Pdgfb deletion in the developing vascu-
lature.6,7,10,12,15,22 To assess if inducible ablation of
endothelium-derived Pdgfb has an effect on brain
mural cell coverage after the brain vasculature is fully
developed in adults, we investigated capillary pericyte
coverage in control and PdgfbiECKO mice at both
young and old age. Low magnification images revealed
a substantial loss of ANPEP-positive pericytes in
PdgfbiECKO mice compared with controls already at
4 months of age (2 months after Pdgfb deletion),
and this became more pronounced in 12- and
18-months-old mice (Figure 1(c)). At high magnifica-
tion, the pericyte processes in PdgfbiECKO mice
appeared thinner, partly detached and with discontin-
uous ANPEP staining (Figure 1(d), white arrowheads).
Pericytes in PdgfbiECKO mice extended shorter process-
es compared with control mice, leaving stretches of the
vasculature uncovered (Figure 1(d), yellow arrow-
heads). In addition, we observed pericytes with altered
cell body morphology and shorter foot-like cytoplas-
mic processes, which were not seen in control animals
(Figure 1(d), asterisk).
Quantitative PCR analysis of isolated microvascular
fragments showed significant reduction of several
known pericyte markers, including Pdgfrb (34%
remaining), Anpep (38%), Abcc9 (31%) and Kcnj8
(37%) in PdgfbiECKO when compared with littermate
controls in 4-months-old mice (Figure 1(e)) and these
markers were also decreased in old PdgfbiECKO mice
when compared with controls (Pdgfrb (45%), Anpep
(29%), Abcc9 (27%) and Kcnj8 (32%)) (Figure 1(e)).
Immunofluorescence staining using anti-desmin (DES)
and anti-PDGFRB antibodies confirmed that the peri-
cyte markers expression in PdgfbiECKO were reduced
overall (Figure 1(f)).
Quantification of longitudinal capillary coverage by
ANPEP-positive pericytes showed a significant reduc-
tion in pericyte coverage in the cerebral cortex with
4-month-old PdgfbiECKO mice (74% coverage remain-
ing) which was further reduced in 12-and 18-month-old
mice (43% coverage remaining) when compared with
controls (100%) (Figure 1(g)). Quantification of endo-
thelial cell (EC) (ERGþ, Hoechstþ) to pericyte (PC)
ratio (ANPEPþ, Hoechstþ) demonstrated increase
from controls (which had 4 EC per 1 PC) in both 4-
month-old (7 EC per 1 PC) and 12- and 18-month-old
PdgfbiECKO mice (8 EC per 1 PC) (Figure 1(h)). In the
18-month-old litter, two of the control animals died
before analysis, leaving us with only one littermate con-
trol for the comparison. In order to appreciate if there
is further pericyte reduction in the 18-month-old litter,
we quantified pericytes separately in 12- and 18-month-
old brains. Pericyte longitudinal coverage was slightly
decreased in 18-month-old mice (33% coverage
remaining) compared to 12-month-old PdgfbiECKO
mice (44% coverage remaining) (Suppl. Fig. 2A), how-
ever the EC/PC ratio (8 EC per 1 PC) remained the
same at both ages (Suppl. Fig. 2B). Total vascular
length (Suppl. Fig. 2C) and total ERGþ endothelial
cell numbers per field remained unaltered at all studied
ages (Suppl. Fig. 2D). Additionally, we did not observe
any obvious vessel dilation in PdgfbiECKO brains
(Figure 1(c), (d) and (f)), an otherwise characteristic
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Figure 1. Experimental scheme, gene deletion efficiencies and assessment of pericytes in adult-induced PdgfbiECKO and littermate
controls. (a) Endothelial-specific Pdgfb deletion was accomplished by Tamoxifen administration for 5 days at 2months of age. All
analyzes were performed at 4months of age for the “young” age and at 12- and 18-months for the “old” age. (b) qPCR analysis of
Pdgfb mRNA expression on freshly isolated brain microvascular fragments. Pdgfb mRNA expression was normalized to endogenous
Gapdh levels. In young mice, 8% of Pdgfb expression remained in PdgfbiECKO mice (n¼ 10). In old mice, 4% of Pdgfb expression
remained in PdgfbiECKO mice (PdgfbiECKO n¼ 11, Ctrl n¼ 10). (c) Representative overview images of mural cells from the cortex of
young and old mice. Co-immunolabeling of PECAM1 (magenta) and ANPEP (cyan). Scale bars 50mm. (d) Representative high mag-
nification images to visualize pericyte morphology in young and old PdgfbiECKO and controls. Co-immunolabeling of PECAM1
(magenta) and ANPEP (cyan). White arrowheads indicate fragmented pericyte processes. Asterisk indicates pericytes with altered cell
bodies and distinct foot processes in PdgfbiECKO. Yellow arrowheads indicate shorter processes leaving part of the vasculature
uncovered in PdgfbiECKO. Scale bars 10 mm. (e) qPCR analysis on the mural cell genes Pdgfrb and Anpep and the pericyte genes Abcc9
and Kcnj8 performed on freshly isolated brain microvascular fragments from young and old mice (for litter and n number see
Supplementary Table 1). The genes of interest were normalized to endogenous Gapdh levels and are presented as relative gene
Continued.
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vascular phenotype observed in mouse models with
developmental pericyte loss.6,7,10,15 There was also no
regional difference in pericyte coverage, in EC/PC ratio
or EC number per field (Suppl. Fig. 2E, F, G), however
there was a reduction in vascular density in the cortex
of 12-month-old PdgfbiECKO mice when compared to
controls (Suppl. Fig. 2H).
Similar to brain, retinal vasculature showed decrease
in longitudinal coverage of ANPEP-positive pericytes
in all three vascular plexuses in 4-month-old mice
(Figure 2(a)). The largest loss was observed and quan-
tified in superficial vascular plexus (54% coverage
remaining), whereas the intermediate and deep plexuses
showed a lower degree of pericyte loss (73 and 71%
Figure 1. Continued.
expression to Ctrl samples. (f) Representative overview images from the cortex of old mice. Co-immunolabeling of PDGFRB
(magenta), DES (green) and PECAM1 (white). Scale bars 25mm. (g) The skeletal length of PECAM1 positive capillaries and ANPEP
positive pericytes in PdgfbiECKO and controls was measured and plotted as the percentage of pericyte longitudinal length over blood
vessel length. Three litters were analyzed for pericyte coverage in the cortex of young mice (PdgfbiECKO n¼ 11, Ctrl n¼ 8) and five
litters were analyzed for coverage in the cortex of old mice (PdgfbiECKO n¼ 16, Ctrl n¼ 13). (h) Quantification of endothelial cell
(ERGþ) to pericyte (ANPEPþ, DAPIþ) ratio per field in young (PdgfbiECKO n¼ 11, Ctrl n¼ 8) and old mice (PdgfbiECKO n¼ 16, Ctrl
n¼ 13). b, g and h-Old, normality tests revealed that the data was unevenly distributed so nonparametric Mann-Whitney U test was
used to evaluate significance. e and h-Young, the significance of evenly distributed data was evaluated using unpaired 2-tailed t test with
Welch’s correction. e, Gene expression comparison between young and old PdgfbiECKO mice was not significant for neither of the four
genes. Data is presented as geometric mean with geometric SD. **p< 0.01, ***p¼ 0.001, ****p< 0.0001, ns¼ not significant.
Figure 2. Assessment of pericytes in adult-induced PdgfbiECKO and littermate control retinas (a) Representative overview images of
mural cells from the retinal plexuses of young mice. Co-immunolabeling of PECAM1 (magenta) and ANPEP (cyan). Scale bars 50 mm.
(b) The skeletal length of PECAM1 positive capillaries and ANPEP positive pericytes in PdgfbiECKO and control plexuses were
measured and plotted as the percentage of pericyte longitudinal length over blood vessel length (PdgfbiECKO n¼ 4, Ctrl n¼ 3).
(c) Representative high magnification images to visualize pericyte morphology in young PdgfbiECKO and controls. Co-immunolabeling of
PECAM1 (magenta) and ANPEP (cyan). White arrowheads indicate fragmented pericyte processes. Yellow arrowheads indicate
shorter processes leaving part of the vasculature uncovered in PdgfbiECKO. Scale bars 25mm. (d) Representative overview images from
young mice. Co-immunolabeling of PDGFRB (magenta), DES (green) and PECAM1 (white). Scale bars 50mm.
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coverage remaining, respectively), which was similar in
magnitude to the brain (Figure 2(b)). The total length
of retinal vasculature (Suppl. Fig. 2I) and total ERGþ
endothelial cell numbers per field were comparable
in mutants and controls in all three plexuses (Suppl.
Fig. 2 J). Observation at high magnification revealed
that pericyte processes in retinas of PdgfbiECKO mice
were thinner, partly detached and displayed discontin-
uous ANPEP staining (Figure 2(c)), which resembled
the mutant brain pericyte phenotype. Also the pericyte
markers DES and PDGFRB were reduced in the
4-months-old retinas (Figure 2(d)). Analysis of
18-month-old control (n¼ 1) and PdgfbiECKO (n¼ 2)
retinas showed further loss of pericyte coverage with-
out any obvious vascular dilation when compared to
4-month-old retinas (Suppl. Fig. 2K), again similar to
the observations in brain.
Next, the PdgfbiECKO mice were analyzed 2weeks
after tamoxifen induction (Suppl. Fig. 3A) in order
to examine whether there was any pericyte loss shortly
after Pdgfb gene deletion, and if pericyte death could be
recorded. Anti-ANPEP immunostaining showed a
slight (12%) but significant decrease in pericyte longi-
tudinal coverage (Suppl. Fig. 3B, white arrowhead, C).
However, there was no significant difference in EC/PC
ratio (Suppl. Fig. 3D), vascular length (Suppl. Fig. 3E)
or total number of ERGþ endothelial cells per field
(Suppl. Fig. 3F). Staining for the apoptotic cell
marker Cleaved-CASPASE3 showed that very few
cells were undergoing apoptosis at this time in
both PdgfbiECKO and littermate control brains (Suppl.
Fig. 3H). A small number of these were positive for
PECAM1, indicating that they were endothelial cells
(Suppl. Fig. 3G, white asterisk and H), and even
fewer were perivascular cells (Suppl. Fig. 3G, white
arrowhead and H). These observations suggest that
PDGFB is important for the maintenance of pericyte
coverage during vascular homeostasis in the adult
brain, and further that pericyte degeneration following
Pdgfb ablation is a slow process. While we failed to
observe increased apoptotic pericytes by staining for
Cleaved-CASPASE3, we cannot exclude the possibility
that pericyte apoptosis takes place but remains too
asynchronous and/or fast to be captured using immu-
nohistochemical detection.
In contrast to pericyte coverage, arteriolar VSMC
coverage was only moderately affected in PdgfbiECKO
mice when compared to littermate controls (Figure 3(a)
to (c)). Immunofluorescence staining with ACTA2
antibodies showed even vascular coverage by VSMC
in brain and retina of control mice, while it was slightly
irregular in shape and sparser in the PdgfbiECKO mice
(Figure 3(a) and (b)). More specifically, there was an
occasional patchy loss of expression of ACTA2 in
PdgfbiECKO mice, leaving gaps in the ACTA2 staining,
similar to but less extensive than what has previously
be reported for Notch3 knockouts27 (Figure 3(a) and
(b), white arrows). Upon closer examination of both
brain and retina, we found that while ACTA2 staining
terminates bluntly at points of arteriolar-capillary tran-
sition in control mice (Figure 3(a) and (b), yellow
arrowheads) the VSMCs stretched out and assumed
an elongated pericyte-like morphology at these sites
in PdgfbiECKO mice (Figure 3(a) and (b), white arrow-
heads). qPCR of the VSMC markers Acta2 and Tagln
showed a significant reduction in brains of old mice
(Acta2 (61% remaining) and Tagln (55% remaining)),
whereas the difference was not significant in young
mice (Figure 3(c)).
Effects of adult loss of pericytes on the mouse
brain vasculature
Previous analyses have shown that developmental loss
of pericytes, as occurs in constitutive Pdgfb mutants
including Pdgfbret/ret and other adult-viable Pdgfb
loss-of-function mouse models, has a number of differ-
ent consequences for brain vascular structure and func-
tion.9,10,13–15,28,29 These include the formation of a
sparser network of wider capillaries, the specific reduc-
tion in the expression of certain BBB transporters,
upregulated endothelial expression of growth factors
and pro-inflammatory molecules, activation of angio-
genic sprouting, the occurrence of two distinct modes
of BBB impairment, i.e. increased transcytosis and hot-
spot leakage via disturbed endothelial junctions, and
the progressive formation of microvascular-associated
calcifications in deep brain regions modeling the
human genetic disease PFBC. Although all of the men-
tioned abnormalities have been documented in adult
Pdgfbret/ret mice, it is not clear whether some or all of
them reflect defective vascular development rather than
a role for pericytes in adult vascular homeostasis. We
therefore studied the vascular consequences of adult-
inducible pericyte loss in PdgfbiECKO mice. As shown
above (Figures 1 to 3), the general capillary rarefaction
and dilation, which hallmarks the Pdgfbret/ret brain vas-
culature, were not reproduced in PdgfbiECKO mice, and
they therefore likely reflect a critical role for pericytes
during developmental brain vascular morphogenesis.
We next analyzed the expression of the capillary-
venous-specific transporters transferrin receptor C
(TFRC) and solute carrier family 16 member 1
(SLC16A1), which are both strongly downregulated
in Pdgfbret/ret mouse brain vasculature.15 Here, ACE2
antibody was used for visualizing the pericytes.18 We
found that both transporters retained normal levels
and distribution of expression in PdgfbiECKO capillaries
and venules (negative in arterioles, Figure 4(a) and (b),
asterisks) devoid of pericytes even in old mice
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(Figure 4(a) and (b), white arrowheads). This suggests
that there is also no change in the endothelial arterio-
venous zonation in PdgfbiECKO, although more
detailed analyses of endothelial gene expression will
be required for a definitive conclusion. Also, adherens
(CDH5) and tight (CLDN5) junctions showed overall
normal expression patterns in vascular stretches devoid
of pericytes in PdgfbiECKO mice (Figure 4(c)), which is
similar to the overall picture of Pdgfbret/ret mouse brain
vasculature.15 However, we found that mRNA levels
for three growth factors/regulators, Fgfbp1, Bmp6
and Angpt2, which are all strongly upregulated in
Pdgfbret/ret brain endothelial cells,15 were also upregu-
lated in the PdgfbiECKO brain endothelium compared
with littermate controls at both young and old age
(Figure 4(d)). Immunofluorescence stainings further
showed that capillary stretches without pericyte contact
had increased ANGPT2 expression both in cortex
(Figure 4(e)) (white arrowheads and inset) and hippo-
campus (Figure 4(f)) (white arrowheads and inset ii) in
old PdgfbiECKO brains. We were not able to confirm the
increased ANGPT2 expression by immunofluorescence
in young PdgfbiECKO brains. On the other hand, leuko-
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Figure 3. Assessment of arteriolar VSMCs (aaVSMCs) in adult-induced PdgfbiECKO and littermate controls. (a) Representative images
of aaVSMC in young (PdgfbiECKO n¼ 4, Ctrl n¼ 2) and old mice (n¼ 3): co-immunolabeling of ACTA2 (red) and PECAM1 (white).
Scale bars 30mm. Dashed inserts are magnified for detailed visualization of ACTA2 expression and aaVSMC morphology. (b)
Representative images of aaVSMC in young retinas (PdgfbiECKO n¼ 4, Ctrl n¼ 3): co-immunolabeling of ACTA2 (red) and PECAM1
(white). Scale bars 25mm. In a and b, white arrows indicate patchy loss of ACTA2 expression leaving small, empty gaps of aaVSMC
coverage along the vasculature. Yellow arrowheads indicate ACTA2 positive terminal aaVSMC at the branching arterioles in Ctrl
samples, where they appeared to end sharply while in PdgfbiECKO they were stretched out and elongated (white arrowheads).
(c) qPCR analysis on the mural cell genes Acta2 and Tagln performed on freshly isolated brain microvascular fragments (for litter and n
number see Supplementary Table 1). The genes of interest were normalized to endogenous Gapdh levels and they are presented as
relative gene expression to Ctrl samples. c-Old (Tagln), Normality tests revealed that the data was unevenly distributed so non-
parametric Mann-Whitney U test was used to evaluate significance. c-Young (Acta2, Tagln) and c-Old (Acta2), The significance of evenly
distributed data was evaluated using unpaired 2-tailed t test with Welch’s correction. *p< 0.05, **p< 0.01, ***p< 0.001 and
****p< 0.0001, two-tailed student’s t-test. Data is presented as geometric mean with geometric SD.
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Figure 4. Characterization of endothelial cell response to pericyte loss in adult-induced PdgfbiECKO. (a) Representative images from
the cortex of old PdgfbiECKO (n¼ 7) and littermate controls (n¼ 6). Co-immunolabeling of COLIV (red), ACTA2 (white), ACE2
(magenta) and TFRC (green). Scale bars 25mm. (b) Representative images from the cortex of old PdgfbiECKO (n¼ 7) and littermate
controls (n¼ 6). Co-immunolabeling of PODXL (red), ACTA2 (white), ANPEP (magenta) and SLC16A1 (green). Arrowheads mark
Continued.
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upregulated in capillaries of both young and old brains
and young retinas (Figure 4(g) and Suppl. Fig. 4).
Pdgfb loss-of-function models with developmental
pericyte hypoplasia show increased BBB permeability
for different molecular weight tracers, which correlates
with the degree of pericyte-deficiency in the particular
model.10,15 In order to assess whether adult-induced
pericyte loss causes vascular permeability in
PdgfbiECKO mice, we measured intravenously injected
Alexa Fluor 555 Cadaverine (1 kDa) accumulation in
the brain after 2 h circulation, a protocol that readily
detects BBB leakage in Pdgfbret/ret mice (with 25% lon-
gitudinal pericyte coverage).10,15 Using this protocol,
we detected a significant increase in BBB permeability
in old PdgfbiECKO mice compared to their littermate
controls (Figure 5(a)). Although we noticed a similar
trend also in young PdgfbiECKO mice, this difference
was not statistically significant (Figure 5(a)). We
could not detect Alexa Fluor 555 Cadaverine leakage
in any of the 4-month-old retinal plexuses (Figure 5
(b)). To assess if hotspot BBB leakage sites occurred
in old PdgfbiECKO mice similar to the situation in
Pdgfbret/ret mice, we systemically injected 70 kDa
tetramethylrhodamine-dextran (TMR-dextran) and
analyzed the mice after 16 h of tracer circulation.
Macroscopical fluorescence analysis did not reveal
any increased permeability (Figure 5(c)), unlike the sit-
uation in Pdgfbret/ret mice.15 However, by assessing the
presence of extravascular TMR-dextran hotspots in the
brain sections together with endothelial and pericyte
markers (PECAM1 and ANPEP, respectively), we
detected hotspots in the different regions of old
PdgfbiECKO mouse brains (Figure 5(d)) albeit at lower
abundance compared to Pdgfbret/ret mice.15 Vascular
stretches associated with TMR-dextran leakage were
invariably dilated and devoid of pericytes (Figure 5
(d)) and surrounded by activated microglia (Figure 5
(e)). We found approximately 4 hotspots per section in
the PdgfbiECKO mice while <1 was detected in the con-
trols (Figure 5(f)). For comparison, Pdgfbret/ret brains
displayed approximately 50 hotspots per section.15 As
in Pdgfbret/ret brains, the TMR-dextran hotspots in
PdgfbiECKO mouse brains showed abnormal distribu-
tion of the junctional proteins CDH5 and CLDN5
(Figure 5(g)), decreased SLC16A1 and TFRC expres-
sion (Figure 5(h)), increased ICAM1 expression
(Figure 5(l)) and undetectable ANGPT2 (Figure 5(j)).
Taken together, we observed similar, albeit less exten-
sive, BBB abnormalities in old PdgfbiECKO mouse
brains as in Pdgfbret/ret mice.
Finally, since mice hypomorphic for Pdgfb and
humans haploinsufficient for PDGFB develop vessel-
associated calcifications in the brain,9 we asked if
adult-onset deletion of Pdgfb triggers capillary calcifi-
cation. We performed immunohistochemical analysis
of vessel-associated calcifications by staining for three
different proteins that selectively accumulate in calcifi-
cations, amyloid precursor protein (APP), amyloid pre-
cursor like protein-2 (APLP2) and osteopontin
(SPP1)13,,28 in old control and PdgfbiECKO mice. Four
to six 75 mm-thick sagittal sections were analyzed per
mouse, with sections chosen to include both outer
cortex and deep brain regions in the analysis, the
latter known to harbor abundant calcifications in
Pdgfbret/ret mice. In altogether 16 PdgfbiECKO and 12
control mice, we detected only a single calcification in
one of the 12-months-old PdgfbiECKO mice (Suppl. Fig.
5A). Analysis of two additional 12-months-old control
and PdgfbiECKO mice using various histochemical
stains, including Alizarin Red, did not reveal any
signs of vessel-associated calcification (data not
shown). Presence of osteopontin (SPP1) has been
noticed in small non-calcified vessel-associated nodules
in Pdgfbret/ret brain thalamus and midbrain regions.28
While we could identify rare small SPP1 positive nod-
ules associated with the vasculature in the thalamus
Figure 4. Continued.
capillaries without pericyte contact. Asterisks mark ACTA2þ arteries/arterioles. Scale bars 25mm. (c) Representative images from the
cortex of old PdgfbiECKO (n¼ 7) and littermate controls (n¼ 6). Co-immunolabeling of CDH5 (green), CLDN5 (magenta) and ACE2
(white) positive pericytes. Scale bars 25mm. Dashed insets are magnified for detailed visualization of junctions. (d) qPCR analysis on
the endothelial cell genes Fgfbp1, Bmp6 and Angpt2 performed on freshly isolated brain microvascular fragments in young and old mice
(for litter and n number see Supplementary Table 1). The genes of interest were normalized to endogenous Gapdh levels (DCq) and
these are presented as arbitrary units (a. u.). For old (Angpt2), normality tests revealed that the data was unevenly distributed so
nonparametric Mann-Whitney U test was used to evaluate significance. For young (Angpt2, Fgfbp1 and Bmp6) and old (Fgfbp1 and
Bmp6), the significance of evenly distributed data was evaluated using unpaired 2-tailed t test with Welch’s correction. *p< 0.05,
**p< 0.01, ***p< 0.001 and ****p< 0.0001. Data is presented as geometric mean with geometric SD. (e, f) Representative images
from the cortex (E) and hippocampus (F) of old PdgfbiECKO and littermate controls. Co-immunolabeling of PECAM1 (white) and
ANGPT2 (green) and ANPEP (magenta). Arrowheads mark capillaries with ANGPT2 expression and without pericyte contact. In
(e) dashed inset shows a magnified ANGPT2þ vessel lacking ANPEP expression in the PdgfbiECKO. n¼ 9, scale bar 10mm. In (f),
zoomed image of ANGPT2 marker expression in a Ctrl (i) and PdgfbiECKO mouse hippocampus (ii). PdgfbiECKO (n¼ 2) and littermate
controls (n¼ 3). Scale bars 50mm. (g) Representative images from the cortex of old PdgfbiECKO (n¼ 10) and littermate controls
(n¼ 9). Co-immunolabeling of COLIV (cyan) and ANPEP (red) and ICAM1 (white). Arrowheads mark capillaries with ICAM1
expression and without pericyte contact. In yellow, the vein is marked as “v”. Scale bars 25mm.

























































































































































































































Figure 5. Analysis of blood-brain and blood-retina barrier permeability in adult-induced PdgfbiECKO compared to littermate controls.
(a) Quantification of 1 kDa Alexa Fluor 555 cadaverine permeability in young (2 independent experiments, PdgfbiECKO n¼ 6, Ctrl
n¼ 5) and old (2 independent experiments PdgfbiECKO n¼ 6, Ctrl n¼ 3) mice after 2 h circulation. Y-axis shows the fold change in
permeability in relation to controls. The significance was evaluated using unpaired 2-tailed t test with Welch’s correction. *p< 0.05,
ns¼ not significant. Data is presented as geometric mean with geometric SD. (b) Representative images of 1 kDa Alexa Fluor 555
cadaverine tracer permeability in young (PdgfbiECKO n¼ 4, Ctrl n¼ 3) retinal plexuses after 2 h circulation. Co-immunolabeling of
PECAM1 (white), ANPEP (magenta), tracer (red) did not show any vascular leakage. Scale bars 50mm. (c) Representative images of
whole brains and kidneys after overnight circulation of 70 kDa TMR-dextran in old mice (two litters, PdgfbiECKO n¼ 7, Ctrl n¼ 6).
Scale bars 2mm. (d) Representative images of the leakage in old mice. Co-immunolabeling of PECAM1 (white), ANPEP (magenta),
Continued.
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and midbrain regions, these were found both in control
and PdgfbiECKO brains (Suppl. Fig. 5B). We also could
not detect any calcifications at hotspot leakage sites
(Suppl. Fig. 5C). Based on these observations, we con-
clude that loss of Pdgfb must take place during devel-
opment in order for vascular calcifications to develop,
at least at a size and abundance detectable by our cur-
rent protocols.
Discussion
It is well established that endothelial-derived PDGFB
is crucial for pericyte recruitment during embryonic
and early postnatal brain vascular development, an
effect mediated by stimulation of pericyte proliferation
and migration via PDGFRB.4–7,20,21 Adult-viable con-
stitutive Pdgfb loss-of-function mutants with strongly
reduced pericyte coverage acquire abnormal brain vas-
culature including general microvessel dilation and rar-
efaction, skewed endothelial arterio-venous zonation,
reduced expression of specific transporters, two
models of BBB leakage, and regional microvascular
calcification.9,10,13–15,28,29 In this study, using an
adult-inducible model of Pdgfb ablation, we demon-
strate that endothelial-derived PDGFB is also required
for adult maintenance of pericyte coverage, but that the
slowly progressing pericyte loss that follows upon
adult-induced Pdgfb ablation causes some, but not
all, of the abnormalities observed in constitutive
Pdgfb mutants.
The partially different consequences of constitutive
or inducible Pdgfb ablation raises questions about the
importance of the developmental state during which
Pdgfb ablation takes place, as well as the extent of
ablation. In general, it is difficult to obtain complete
gene deletion in adult tissues using tamoxifen-inducible
strategies. We have previously shown that the consti-
tutive absence of one functional Pdgfb allele, leading to
a 50% loss of Pdgfb transcripts, is not sufficient to
render a significant alteration in pericyte density in
the brain vasculature.25 Apparently, a threshold level
of Pdgfb expression exists below (or at) 50% of normal,
which is sufficient for the maintenance of normal peri-
cyte numbers. Park et al. reported that deletion of
Pdgfb using Cdh5-CreERT2 at 8-weeks of age followed
by analysis at 12-weeks of age did not lead to altered
pericyte morphology or coverage in the mouse retina.22
The difference to our current findings reflects that a
longer time of Pdgfb depression was needed to cause
pericyte loss also in the retina. A second possibility is
that a sufficiently high gene deletion efficiency was not
obtained - this was not assessed in the study.22
In our own study, >90% loss of endothelium-
derived Pdgfb at 2 months of age resulted in 54–74%
(in 4-moths-old retina and brain) and 43% (in 12- and
18-months-old brain) remaining longitudinal pericyte
coverage compared with controls. Residual pericytes
further displayed abnormal phenotypes in that their
cell bodies were frequently rounded and partially
detached from the endothelium, and their processes
appeared thinner, partially detached and with altered
secondary foot processes than in controls. With these
observations, we propose that endothelium-derived
Pdgfb is necessary for the maintenance of a normal
pericyte phenotype, as well as for long term mainte-
nance of normal pericyte numbers.
Although we detected changes in arteriolar VSMC
morphology and coverage in PdgfbiECKO mice, brain
and retinal arteriolar VSMC appeared less sensitive
to Pdgfb loss than pericytes. A similar discrepancy
Figure 5. Continued.
70 kDa TMR-dextran (red) in thalamus. Dashed inset shows a 70 kDa TMR-dextran hotspot on an enlarged capillary lacking pericyte
contact (two litters, PdgfbiECKO n¼ 7, Ctrl n¼ 6). Scale bars 25mm. (e) Representative images of the cerebral cortex of old mice.
Co-immunolabeling of PECAM1 (white), IBA1 (green) and 70 kDa TMR-dextran (red). Dashed inset shows a 70 kDa TMR-dextran
hotspot on an enlarged capillary surrounded by activated microglia (IBA1þ cells) (two litters, PdgfbiECKO n¼ 7, Ctrl n¼ 6). Scale bars
25mm. (f) Quantification of extravascular 70 kDa TMR-Dextran hotspots in old mice (two litters, PdgfbiECKO n¼ 7, Ctrl n¼ 6). Y-axis
shows the average number of hotspots detected per brain sections from each mouse. The significance was evaluated using unpaired
2-tailed t test with Welch’s correction. *p< 0.05. Data is presented as mean SD. (g) Representative images of the midbrain of aged
mice. Co-immunolabeling of PECAM1 (white), CLDN5 (cyan), CDH5 (green) and 70 kDa TMR-dextran (red). Dashed inset shows a
70 kDa TMR-dextran hotspot on an enlarged capillary with disturbed junctional expression (two litters, PdgfbiECKO n¼ 7, Ctrl n¼ 6).
Scale bars 25mm. (h) Representative images of the basal forebrain of old mice. Co-immunolabeling of PODXL (white), SLC16A1
(magenta), TFRC (green), ACTA2 (cyan), and 70 kDa TMR-dextran (red). The arterioles are marked as “aa” in yellow. Dashed inset
shows a 70 kDa TMR-dextran hotspot on an enlarged capillary with decreased expression of the endothelial proteins SLC16A1
and TFRC (two litters, PdgfbiECKO n¼ 7, Ctrl n¼ 6). Scale bars 25mm. (i) Representative images of the midbrain of old mice.
Co-immunolabeling of COLIV (White), ANPEP (magenta), ICAM1 (cyan) and 70 kDa TMR-dextran (red). In yellow, the arterioles are
marked as “aa” and the veins as “v”. Dashed inset shows a 70 kDa TMR-dextran hotspot on an enlarged capillary lacking pericyte
contact with unusual expression of ICAM1 (two litters, PdgfbiECKO n¼ 7, Ctrl n¼ 6). Scale bars 25mm. (j) Representative images of
the thalamus of old mice. Co-immunolabeling of COLIV (White), ANPEP (magenta), ANGPT2 (cyan) and 70 kDa TMR-dextran (red).
Dashed inset shows a 70 kDa TMR-dextran hotspot on an enlarged capillary lacking pericyte contact with no expression of ANGPT2
(two litters, PdgfbiECKO n¼ 7, Ctrl n¼ 6). Scale bars 25mm.
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was observed in constitutive Pdgfb or Pdgfrb knockout
mutants, which showed residual arteriolar VSMC cov-
erage in spite of strongly reduced number of peri-
cytes.4,5 Of note, brain arterial VSMC also express
significant levels of Pdgfd, which encodes PDGFD,
another PDGF ligand with affinity for PDGFRB18
thus possibly compensating for the loss of paracrine
PDGFB from endothelial cells.
Because Pdgfbret/ret mice display two distinct modes
of BBB permeability – increased transcytosis and focal
hotspot leakage,10,15 we were interested to know how
inducible adult pericyte loss affects BBB permeability.
We found that 4-months-old PdgfbiECKO mouse retinas
and brains with 54–74% longitudinal pericyte coverage
did not display significantly increased leakage of
Alexa Fluor 555 cadaverine while 12–18-months-old
PdgfbiECKO mice brains with 43% longitudinal pericyte
coverage did. We have previously demonstrated that
adult-viable Pdgfb single allele rescue mice (R26Pþ/0)
with 40% pericyte coverage showed a leaky BBB,
whereas Pdgfb double allele rescue mice (R26Pþ/þ)
with 72% pericyte coverage did not.10 Thus, the induc-
ible and constitutive mutants suggest a similar thresh-
old level of pericyte coverage (>50%) beyond which
further pericyte loss causes BBB disruption.
Interestingly, >50% pericyte loss also correlated with
the development of proliferative retinopathy in
endothelial-specific constitutive Pdgfb knockouts.20
Others have reported that 20% reduced pericyte cover-
age disrupts the BBB,30 an observation that we cannot
confirm using our adult-inducible Pdgfb knockout and
methods for BBB leakage measurements.
Developmental loss of pericytes results in skewed
vascular arterio-venous zonation.15 When analyzing
the capillary-venous marker, TFRC and SLC16A1,
expression in old PdgfbiECKO brain vasculature, we
could not detect any general loss of their expression
in capillary stretches devoid of pericytes. However,
the hotspot leakage sites had lost or reduced expression
of SLC16A1 and TFRC. Similar to the situation for
developmental loss of pericytes, adherens and tight
junction protein expression pattern were generally
normal in adult induced old PdgfbiECKO brain vascula-
ture, while hotspot leakage sites showed abnormalities
in both CDH5 and CLDN5 expression and distribu-
tion. Taken together, adult loss of pericytes did not
affect general endothelial arterio-venous hierarchy or
EC junctions, although both were disturbed at focal
hotspot leakage sites.
We found upregulation of growth factors that are
normally expressed during vascular development and
in Pdgfbret/ret mice also in adult-induced PdgfbiECKO
brain vasculature. In further similarity to Pdgfbret/ret,
ANGPT2 was not expressed at hotspot leakage sites in
PdgfbiECKO brains, but rather in pericyte-deficient vas-
cular stretches without leakage. This suggests that
ANGPT2 plays a protective role for the BBB in
adult-induced PdgfbiECKO similar to the situation in
Pdgfbret/ret mice.15 ICAM1 was upregulated already
in the young brain and retinal capillaries devoid of
pericytes, indicating early focal vascular activation. In
old brains ICAM1 upregulation also coincided with
hotspot leakage sites.
A second unexpected finding was the lack of
nodular microvascular calcifications in the brains of
adult-induced PdgfbiECKO mice. Vessel-associated cal-
cifications with a pattern resembling human PFBC
have previously been reported in constitutive hypomor-
phic mutations in Pdgfb.9 Despite an exhaustive search,
we found only a single nodular brain calcification in a
single PdgfbiECKO mouse. Brain vascular calcification is
associated with several brain diseases as well as in aging
in humans, and our singular finding therefore neither
confirms nor refutes a causal link to Pdgfb. Regardless,
given the abundant vascular calcification observed in
Pdgfbret/ret mice, it seems reasonable to assume that its
development and progression during adult age requires
PDGFB deficiency from young age. In summary,
our study discriminates between developmental and
homeostatic roles for Pdgfb and pericytes in the
brain. The latter may be relevant for the several
neuro-pathological conditions in which acquired peri-
cyte loss has been reported.31–37
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